Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Xenetic Biosciences (XBIO) Shares Outstanding (2023 - 2025)

Xenetic Biosciences (XBIO) has disclosed Shares Outstanding for 4 consecutive years, with $1.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding changed 0.0% year-over-year to $1.5 million, compared with a TTM value of $1.5 million through Sep 2025, changed 0.0%, and an annual FY2024 reading of $1.5 million, down 14.38% over the prior year.
  • Shares Outstanding was $1.5 million for Q3 2025 at Xenetic Biosciences, down from $1.8 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $1.8 million in Q2 2024 and bottomed at $1.5 million in Q1 2023.
  • Average Shares Outstanding over 3 years is $1.6 million, with a median of $1.5 million recorded in 2025.
  • Peak annual rise in Shares Outstanding hit 18.76% in 2024, while the deepest fall reached 44.32% in 2024.
  • Year by year, Shares Outstanding stood at $1.8 million in 2023, then decreased by 14.38% to $1.5 million in 2024, then changed by 0.0% to $1.5 million in 2025.
  • Business Quant data shows Shares Outstanding for XBIO at $1.5 million in Q3 2025, $1.8 million in Q2 2025, and $1.8 million in Q1 2025.